脳動脈瘤(Cerebral Aneurysms):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Cerebral Aneurysms Global Clinical Trials Review, H1, 2015
◆商品コード:GDHC2613CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年3月31日
◆ページ数:58
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界における脳動脈瘤(Cerebral Aneurysms) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 脳動脈瘤(Cerebral Aneurysms)
  - 当レポートの概要
・脳動脈瘤(Cerebral Aneurysms):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H1, 2015″ provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cerebral Aneurysms 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Cerebral Aneurysms Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Hope Pharmaceuticals, Inc. 27
Clinical Trial Overview of Hope Pharmaceuticals, Inc. 27
Edge Therapeutics, Inc. 28
Clinical Trial Overview of Edge Therapeutics, Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
Rush University Medical Center 29
Clinical Trial Overview of Rush University Medical Center 29
Guangzhou University of Traditional Chinese Medicine 30
Clinical Trial Overview of Guangzhou University of Traditional Chinese Medicine 30
Isfahan University of Medical Sciences 31
Clinical Trial Overview of Isfahan University of Medical Sciences 31
Juntendo University School of Medicine 32
Clinical Trial Overview of Juntendo University School of Medicine 32
Kwong Wah Hospital 33
Clinical Trial Overview of Kwong Wah Hospital 33
Kyoto University 34
Clinical Trial Overview of Kyoto University 34
Mashhad University of Medical Sciences 35
Clinical Trial Overview of Mashhad University of Medical Sciences 35
Medical University of South Carolina 36
Clinical Trial Overview of Medical University of South Carolina 36
National Cerebral and Cardiovascular Center 37
Clinical Trial Overview of National Cerebral and Cardiovascular Center 37
Samsung Medical Center 38
Clinical Trial Overview of Samsung Medical Center 38
Five Key Clinical Profiles 39
Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 58

List of Tables
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region, 2015* 6
Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 16
Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Cerebral Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Hope Pharmaceuticals, Inc., 2015* 27
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015* 28
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2015* 29
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangzhou University of Traditional Chinese Medicine, 2015* 30
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 31
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 32
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kwong Wah Hospital, 2015* 33
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2015* 34
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 35
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2015* 36
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2015* 37
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 38

List of Figures
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 16
Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 57

【レポートのキーワード】

脳動脈瘤(Cerebral Aneurysms)、治験、臨床試験、治験、治療薬

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 脳動脈瘤(Cerebral Aneurysms):世界の治験レビュー(2015年上半期版)(Cerebral Aneurysms Global Clinical Trials Review, H1, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆